Celine Garrec
Nantes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Author Correction: A founder BRCA1 exonic duplication involving breakpoint in T2T reference genome-specific region results in constitutional fusion transcript.
Journal: NPJ genomic medicine
Published: September 02, 2025
Cancer risks for ATM variant heterozygotes.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: September 01, 2025
Identification of Hepatic-like EPO as a Cause of Polycythemia.
Journal: The New England journal of medicine
Published: April 30, 2025
A founder BRCA1 exonic duplication involving breakpoint in T2T reference genome-specific region results in constitutional fusion transcript.
Journal: NPJ genomic medicine
Published: February 14, 2025
Deciphering dual clinical entities associated with TP53 pathogenic variants: Insights from 53,085 HBOC panel analyses in French laboratories.
Journal: International journal of cancer
Published: September 26, 2024
Deep Learning for Detecting BRCA Mutations in High-Grade Ovarian Cancer Based on an Innovative Tumor Segmentation Method From Whole Slide Images.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: March 31, 2023
Germline JAK2 E846D Substitution as the Cause of Erythrocytosis?
Journal: Genes
Published: March 03, 2023
Characterization of genetic variants in the EGLN1/PHD2 gene identified in a European collection of patients with erythrocytosis.
Journal: Haematologica
Published: February 10, 2023
Comprehensive in silico and functional studies for classification of EPAS1/HIF2A genetic variants identified in patients with erythrocytosis.
Journal: Haematologica
Published: September 01, 2022
Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.
Journal: American journal of human genetics
Published: June 15, 2021
TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel Testing.
Journal: Cancers
Published: June 08, 2021
A de novo pathogenic variant in the MSH6 gene in a 52 years-old woman.
Journal: Familial cancer
Published: May 03, 2021
Last Updated: 09/26/2026